Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

3.12USD
3:59pm BST
Change (% chg)

$0.22 (+7.76%)
Prev Close
$2.90
Open
$3.00
Day's High
$3.15
Day's Low
$3.00
Volume
22,067
Avg. Vol
51,270
52-wk High
$5.75
52-wk Low
$1.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.34 -0.228
FY 2017 Dec '17 0.74 0.480
Sep '17 1.49 -0.281
Jun '17 2.66 -0.288
Mar '17 3.11 -0.343
FY 2016 Dec '16 6.43 -0.214
Sep '16 3.37 -0.252
Jun '16 4.53 -0.245
Mar '16 3.03 -0.242
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 1.38 2.20 0.65 5.56
Quarter Ending Sep-18 3 3.65 7.90 0.55 18.58
Year Ending Dec-18 4 7.72 10.70 2.40 31.21
Year Ending Dec-19 4 21.33 30.10 9.10 77.54
Earnings (per share)
Quarter Ending Jun-18 4 -0.22 -0.19 -0.23 -0.24
Quarter Ending Sep-18 4 -0.20 -0.12 -0.24 -0.05
Year Ending Dec-18 4 -0.93 -0.85 -1.04 -0.82
Year Ending Dec-19 4 -0.89 -0.70 -1.00 -0.07
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.06 32.75
P/E High - Last 5 Yrs. -- 293.32 45.73
P/E Low - Last 5 Yrs. -- 91.63 24.23
Beta 3.03 0.90 0.88
Price to Sales (TTM) 14.87 110.95 5.71
Price to Book (MRQ) -- 13.58 5.37
Price to Tangible Book (MRQ) -- 14.04 6.94
Price to Cash Flow (TTM) -- 71.44 23.33
% Owned Institutions 39.70 12.71 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.32 399.27 9.21
Sales (TTM) vs TTM 1 Yr. Ago -37.00 78.86 5.69
Sales - 5 Yr. Growth Rate 74.52 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -17.56 25.14 19.38
EPS (TTM) vs TTM 1 Yr. Ago -79.25 -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.77
Capital Spending - 5 Yr. Growth Rate 13.00 40.31 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.81 1.81 2.19
Current Ratio (MRQ) 4.92 5.29 2.98
LT Debt to Equity (MRQ) -- 22.98 12.17
Total Debt to Equity (MRQ) -- 24.63 16.44
Interest Coverage (TTM) -1.82 -99.39 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 13.88 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.16 52.21
EBITD Margin (TTM) -225.81 -- --
EBITD - 5 Yr. Avg -161.51 -575.09 10.96
Operating Margin (TTM) -238.47 -718.94 4.73
Operating Margin - 5 Yr. Avg. -170.81 -596.41 6.40
Pre-Tax Margin (TTM) -319.40 -693.40 5.57
Pre-Tax Margin - 5 Yr. Avg. -212.89 -599.76 6.81
Net Profit Margin (TTM) -319.19 -694.62 1.87
Net Profit Margin - 5 Yr. Avg. -213.88 -602.62 3.09
Effective Tax Rate (TTM) -- 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.22 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 399,205 22,637,573 847,064,414
Net Income/Employee (TTM) -1,274,205 2,973,815 99,643,698
Receivable Turnover (TTM) 4.98 20.17 5.78
Inventory Turnover (TTM) 9.22 2.37 3.35
Asset Turnover (TTM) 0.16 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -51.83 -1.09 10.95
Return on Assets - 5 Yr. Avg. -34.34 -0.58 12.32
Return on Investment (TTM) -63.23 1.57 14.38
Return on Investment - 5 Yr. Avg. -39.19 2.21 16.11
Return on Equity (TTM) -- 2.43 16.07
Return on Equity - 5 Yr. Avg. -81.78 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -9.89 -16.21 74.52
EPS (TTM) % -72.93 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AcelRx Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 27.05%
# of Holders: 64
Total Shares Held: 13,881,124
3 Mo. Net Change: -368,616
# New Positions: 8
# Closed Positions: 12
# Increased Positions: 20
# Reduced Positions: 25
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.